Clinical Trials Browser

Withdrawn × Prostatic Neoplasms × Sorafenib × Clear all

NCT00694291 2015-03-06

Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms